A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : OA / oligoastrocytomas

[Related PubMed/MEDLINE]
Total Number of Papers: 27
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   OA  (>> Co-occurring Abbreviation)
Long Form:   oligoastrocytomas
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2018 Posterior fossa recurrence of WHO grade II and III supratentorial gliomas. PF, ST, WHO
2018 Reclassification of Mixed Oligoastrocytic Tumors Using a Genetically Integrated Diagnostic Approach. GBMs
2017 Histological spectrum of oligodendroglial tumors: Only a subset shows 1p/19q codeletion. AOA, AOD, FISH, GBM-O, OD, ODGs
2016 A rare case of oligoastrocytoma with atypical symptoms initially diagnosed as multiple sclerosis: A case report. MS
2016 Development of a transplantable glioma tumour model from genetically engineered mice: MRI/MRS/MRSI characterisation. CDT, GBM, GEM, MRI, MRS/MRSI, ODG, WHO
2016 Genotyping low-grade gliomas among Hispanics. IDH, LGGs, OD, OS
2015 Combined IDH1 mutation and MGMT methylation status on long-term survival of patients with cerebral low-grade glioma. DA, IDH1, LGG, MGMT, OG
2014 Codeletions at 1p and 19q predict a lower risk of pseudoprogression in oligodendrogliomas and mixed oligoastrocytomas. OG, PsP
2014 Farewell to oligoastrocytoma: in situ molecular genetics favor classification as either oligodendroglioma or astrocytoma. ---
10  2013 Neurosurgical treatment of oligodendroglial tumors in children and adolescents: a single-institution series of 35 consecutive patients. BI, OD
11  2012 Detection of 1p19q deletion by real-time comparative quantitative PCR. AO, CQ-PCR, FISH, LOH, OG, OT
12  2012 IDH1/2 mutation is a prognostic marker for survival and predicts response to chemotherapy for grade II gliomas concomitantly treated with radiation therapy. DA, KPS, OL, OS, PFS
13  2010 A phase II trial of primary temozolomide in patients with grade III oligodendroglial brain tumors. CI, MGMT, OD, OS, PFS, RR
14  2009 Apparent diffusion coefficient and fractional anisotropy of newly diagnosed grade II gliomas. AC, ADC, FA, nADC, NAWM, nFA, ODs
15  2009 Characterization of low-grade gliomas using RGB color maps derived from ADC histograms. AC, nADC, NAWM, NEL, OD
16  2009 [Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors]. AO, AOA, OT, TTP
17  2008 Low grade diffuse gliomas: shared cellular composition and morphometric differences. DA, OL
18  2007 Apparent diffusion coefficient histograms may predict low-grade glioma subtype. AC, ADC, OD
19  2007 Oligoastrocytoma presenting with intractable epilepsy. ---
20  2006 Automatized assessment of 1p36-19q13 status in gliomas by interphase FISH assay on touch imprints of frozen tumours. FISH
21  2004 [Prognostic analysis of patients with cerebral glioma treated with radiotherapy]. AC, GBM, KPS, OD
22  2003 Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971. MRI, OD, PCV, TMZ
23  2003 Second-line chemotherapy with temozolomide in recurrent oligodendroglioma after PCV (procarbazine, lomustine and vincristine) chemotherapy: EORTC Brain Tumor Group phase II study 26972. CCNU, CI, OD, TMZ
24  2002 Clonality of oligoastrocytomas. ---
25  2002 The expression of cell cycle regulatory proteins in oligodendroglial tumors. AO, AOA, LI
26  1997 A clinicopathologic study of 30 cases of oligoastrocytoma including p53 immunohistochemistry. MOA
27  1997 Distribution of endogenous tumour necrosis factor alpha in gliomas. AA, AOA, GB, TNF-alpha